| Dr Sangeeta Buddala, MD | |
|
Rt. 72 East, New Lisbon Developmental Center, New Lisbon, NJ 08064 | |
| (609) 726-1000 | |
| Not Available |
| Full Name | Dr Sangeeta Buddala |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 23 Years |
| Location | Rt. 72 East, New Lisbon, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659460509 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 25MAO7340500 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Virtua Willingboro Hospital | Willingboro, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Garden State Physicians P.c. | 5193887370 | 3 |
| State Of New Jersey Omb Centralized Payroll | 6406742592 | 81 |
News Archive
Powdered protein supplements are one of the most commonly consumed nutritional supplements, whether by professional sportspeople or amateurs, even by those who use them for aesthetic purposes instead of sporting ones.
The world's first baby born via in-vitro fertilization turned 40 years old this summer. Still, after four decades, IVF is a relatively new field with ongoing debate on how to get the best results for families who have placed their hopes - and often their personal savings - into fertility treatment.
New Phase II data presented today at the American Diabetes Association 69th Scientific Sessions in New Orleans show that the investigational type 2 diabetes treatment Syncria (albiglutide) significantly reduced blood glucose levels and provided weight loss across weekly, biweekly and monthly dosing. Reducing blood sugar is a key part of managing type 2 diabetes, a disease that affects over 250 million people worldwide.
Quest Diagnostics Incorporated, the world's leading cancer diagnostics company, today announced that its ColoVantage test has been approved by New York State's Department of Health for testing on samples of patients in the state. It is believed to be the first molecular colorectal cancer detection method that employs a venal blood specimen to be approved by the state.
BIOTRONIK, a leading manufacturer of cardiovascular medical devices, announced today that the Food and Drug Administration has granted approval for its Entovis pacemaker system with ProMRI technology.
› Verified 7 days ago
| Entity Name | State Of New Jersey Omb Centralized Payroll |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255375929 PECOS PAC ID: 6406742592 Enrollment ID: O20040323000483 |
News Archive
Powdered protein supplements are one of the most commonly consumed nutritional supplements, whether by professional sportspeople or amateurs, even by those who use them for aesthetic purposes instead of sporting ones.
The world's first baby born via in-vitro fertilization turned 40 years old this summer. Still, after four decades, IVF is a relatively new field with ongoing debate on how to get the best results for families who have placed their hopes - and often their personal savings - into fertility treatment.
New Phase II data presented today at the American Diabetes Association 69th Scientific Sessions in New Orleans show that the investigational type 2 diabetes treatment Syncria (albiglutide) significantly reduced blood glucose levels and provided weight loss across weekly, biweekly and monthly dosing. Reducing blood sugar is a key part of managing type 2 diabetes, a disease that affects over 250 million people worldwide.
Quest Diagnostics Incorporated, the world's leading cancer diagnostics company, today announced that its ColoVantage test has been approved by New York State's Department of Health for testing on samples of patients in the state. It is believed to be the first molecular colorectal cancer detection method that employs a venal blood specimen to be approved by the state.
BIOTRONIK, a leading manufacturer of cardiovascular medical devices, announced today that the Food and Drug Administration has granted approval for its Entovis pacemaker system with ProMRI technology.
› Verified 7 days ago
| Entity Name | Garden State Physicians P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518115542 PECOS PAC ID: 5193887370 Enrollment ID: O20081222000646 |
News Archive
Powdered protein supplements are one of the most commonly consumed nutritional supplements, whether by professional sportspeople or amateurs, even by those who use them for aesthetic purposes instead of sporting ones.
The world's first baby born via in-vitro fertilization turned 40 years old this summer. Still, after four decades, IVF is a relatively new field with ongoing debate on how to get the best results for families who have placed their hopes - and often their personal savings - into fertility treatment.
New Phase II data presented today at the American Diabetes Association 69th Scientific Sessions in New Orleans show that the investigational type 2 diabetes treatment Syncria (albiglutide) significantly reduced blood glucose levels and provided weight loss across weekly, biweekly and monthly dosing. Reducing blood sugar is a key part of managing type 2 diabetes, a disease that affects over 250 million people worldwide.
Quest Diagnostics Incorporated, the world's leading cancer diagnostics company, today announced that its ColoVantage test has been approved by New York State's Department of Health for testing on samples of patients in the state. It is believed to be the first molecular colorectal cancer detection method that employs a venal blood specimen to be approved by the state.
BIOTRONIK, a leading manufacturer of cardiovascular medical devices, announced today that the Food and Drug Administration has granted approval for its Entovis pacemaker system with ProMRI technology.
› Verified 7 days ago
| Entity Name | Plainsboro-princeton Medical Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841442704 PECOS PAC ID: 6507994753 Enrollment ID: O20100507000461 |
News Archive
Powdered protein supplements are one of the most commonly consumed nutritional supplements, whether by professional sportspeople or amateurs, even by those who use them for aesthetic purposes instead of sporting ones.
The world's first baby born via in-vitro fertilization turned 40 years old this summer. Still, after four decades, IVF is a relatively new field with ongoing debate on how to get the best results for families who have placed their hopes - and often their personal savings - into fertility treatment.
New Phase II data presented today at the American Diabetes Association 69th Scientific Sessions in New Orleans show that the investigational type 2 diabetes treatment Syncria (albiglutide) significantly reduced blood glucose levels and provided weight loss across weekly, biweekly and monthly dosing. Reducing blood sugar is a key part of managing type 2 diabetes, a disease that affects over 250 million people worldwide.
Quest Diagnostics Incorporated, the world's leading cancer diagnostics company, today announced that its ColoVantage test has been approved by New York State's Department of Health for testing on samples of patients in the state. It is believed to be the first molecular colorectal cancer detection method that employs a venal blood specimen to be approved by the state.
BIOTRONIK, a leading manufacturer of cardiovascular medical devices, announced today that the Food and Drug Administration has granted approval for its Entovis pacemaker system with ProMRI technology.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sangeeta Buddala, MD 7 Shoreham Ct, East Windsor, NJ 08520-5101 Ph: (609) 371-7997 | Dr Sangeeta Buddala, MD Rt. 72 East, New Lisbon Developmental Center, New Lisbon, NJ 08064 Ph: (609) 726-1000 |
News Archive
Powdered protein supplements are one of the most commonly consumed nutritional supplements, whether by professional sportspeople or amateurs, even by those who use them for aesthetic purposes instead of sporting ones.
The world's first baby born via in-vitro fertilization turned 40 years old this summer. Still, after four decades, IVF is a relatively new field with ongoing debate on how to get the best results for families who have placed their hopes - and often their personal savings - into fertility treatment.
New Phase II data presented today at the American Diabetes Association 69th Scientific Sessions in New Orleans show that the investigational type 2 diabetes treatment Syncria (albiglutide) significantly reduced blood glucose levels and provided weight loss across weekly, biweekly and monthly dosing. Reducing blood sugar is a key part of managing type 2 diabetes, a disease that affects over 250 million people worldwide.
Quest Diagnostics Incorporated, the world's leading cancer diagnostics company, today announced that its ColoVantage test has been approved by New York State's Department of Health for testing on samples of patients in the state. It is believed to be the first molecular colorectal cancer detection method that employs a venal blood specimen to be approved by the state.
BIOTRONIK, a leading manufacturer of cardiovascular medical devices, announced today that the Food and Drug Administration has granted approval for its Entovis pacemaker system with ProMRI technology.
› Verified 7 days ago
Dr. Essam El-harazy, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: Nldc Route 72, New Lisbon, NJ 08064 Phone: 609-726-1000 Fax: 609-726-1387 | |
Dr. Prince G Kottiath, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: Route 72, New Lisbon Developmental Center, Health Services, New Lisbon, NJ 08064 Phone: 609-726-1000 |